Industry Report: CDA Guidance and Template
Accelerating Clinical Trials through Streamlined Confidential Disclosure Agreements and Processes
The Site-Sponsor Consortium’s inaugural deliverable tackles an early bottleneck in study startup: the Confidential Disclosure Agreement (CDA). This industry report outlines why CDAs should remain simple and mutual, how to avoid common pitfalls, and when a master CDA removes rework—so study feasibility can begin sooner. The companion Master Mutual CDA Template turns guidance into action, paving a faster and simpler path to feasibility assessments, site selection, and startup planning.

Our Vision
A future where sites, CROs, and sponsors work together seamlessly, fostering innovation, reducing complexities, and bringing life-changing treatments to patients faster.
Our Mission
To expedite clinical research today by co-creating vendor-agnostic deliverables that drive progress, strengthen collaboration, and dismantle operational silos—fostered through an environment of open dialogue, shared knowledge, and strategic innovation.
Site-Sponsor Consortium Members
Jamie Bendrick-Peart
Senior Director, Innovation & Strategic Projects
AstraZeneca
Kari Delahunty
Chief Operating Officer
AMR Clinical
Alison Foster
VP, Strategic Delivery & Growth
Fortrea
Alison Liddy
SVP, Patient & Site Centric Solutions
IQVIA
Kristie Moffett
Senior Director, Human Subjects Research
Moffitt Cancer Center
Rhonda Paz
Executive Director, Investigative Services Group
Yale University
Nicholas Spittal
Chief Operations Officer
Velocity Clinical Research
Ian Wyglednowski
VP, Global Head of Strategic Clinical Partnering
UCB Biosciences
Kyle Burtnett
Chief Executive Officer
Headlands Research
Nicholas Fisher
Executive Director, Research & Business Administration
Alvin J. Siteman Cancer Center at Washington University School of Medicine & Barnes Jewish Hospital
Teri Karcher
President, Global Project Leadership & Launch Excellence
Parexel
Timothy Mudric
VP, Global Therapeutic Area Head: Neuroscience and Ophthalmology
PPD, part of Thermo Fisher Scientific
Marisa Rackley
VP, Study Optimization, Clinical Site Startup & Site Engagement
Takeda
Walter Stadler
Chief Clinical Officer
City of Hope
Jennifer Byrne
Chief Executive Officer
Javara
Patrick Floody
VP, Global Clinical Trial Services
Regeneron
Adam Kinsey
Associate VP, Clinical Operations; Regional Head North America
Merck
Carlos Orantes
Chief Executive Officer
Alcanza Clinical Research
Michelle Rowe
VP, Operations, HCA Healthcare Research Institute
HCA Healthcare
Brandi Walker
EVP, Global Clinical Operations
Syneos Health

Shaping the Future of Clinical Research
The consortium is built on three core pillars:
Subscribe to Stay Informed on our Site-Sponsor Consortium
Receive quarterly updates on product developments, meetings, and progress.